Literature DB >> 12881313

Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression.

Gérard Socié1, Jean-Yves Mary, Marc Lemann, Marjan Daneshpouy, Philippe Guardiola, Véronique Meignin, Lionel Ades, Hélène Esperou, Patricia Ribaud, Agnés Devergie, Eliane Gluckman, Jean-Claude Ameisen, Anne Janin.   

Abstract

The gastrointestinal (GI) tract is a major target in graft-versus-host disease (GvHD). In rodents both tumor necrosis factor (TNF) and Fas-dependent apoptosis have been shown to play a major role in GvHD lesions, but data in humans on TNF and Fas in situ expression are scarce. More recently, the role of non-T cells as GvHD effectors has also been suggested in experimental models. Here we report a detailed quantitative pathologic analysis in 95 patients who underwent gastroduodenal biopsy. This analysis included characterization and quantification of the cellular infiltrate, TNF, TNF receptors, and Fas in situ expression analyses and quantification of apoptotic cell numbers. TNF was expressed in all biopsies and it was highly specific for acute GvHD. In multivariate analysis, including pathologic factors only, increased early transplant-related mortality (TRM) was associated with the presence of more than 20 neutrophils per field. Factors affecting early and late TRM were then assessed by multivariate analyses including both pathologic and clinical factors. Increased day-90 TRM was associated with the presence of more than 5 apoptotic bodies per field within the cellular infiltrate, and with stage II or higher acute liver GvHD. One-year TRM associated with the same 2 factors and with chronic GvHD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881313     DOI: 10.1182/blood-2003-03-0909

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  IDO in human gut graft-versus-host disease.

Authors:  Philippe Ratajczak; Anne Janin; Régis Peffault de Larour; Lisa Koch; Brigitte Roche; David Munn; Bruce R Blazar; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-09       Impact factor: 5.742

3.  Th17/Treg ratio in human graft-versus-host disease.

Authors:  Philippe Ratajczak; Anne Janin; Regis Peffault de Latour; Christophe Leboeuf; Allison Desveaux; Keyvan Keyvanfar; Marie Robin; Emmanuel Clave; Corine Douay; Anne Quinquenel; Claire Pichereau; Philippe Bertheau; Jean Yves Mary; Gérard Socié
Journal:  Blood       Date:  2010-05-18       Impact factor: 22.113

4.  Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples.

Authors:  Armin Rashidi; Ryan Shanley; Sophia L Yohe; Bharat Thyagarajan; Julie Curtsinger; Claudio Anasetti; Edmund K Waller; Jeffrey S Miller; Bruce R Blazar; Daniel J Weisdorf
Journal:  Bone Marrow Transplant       Date:  2018-03-07       Impact factor: 5.483

Review 5.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-11-30       Impact factor: 91.245

6.  Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.

Authors:  David Myerson; Gideon Steinbach; Ted A Gooley; Howard M Shulman
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

7.  Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.

Authors:  Y Peng; X Chen; Q Liu; X Zhang; K Huang; L Liu; H Li; M Zhou; F Huang; Z Fan; J Sun; Q Liu; M Ke; X Li; Q Zhang; A P Xiang
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

Review 8.  Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.

Authors:  H Joachim Deeg; Emily Spaulding; Howard M Shulman
Journal:  Leuk Lymphoma       Date:  2009-10

9.  Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.

Authors:  Jo Nadine Fleming; Howard M Shulman; Richard A Nash; Pamela Y Johnson; Thomas N Wight; Allen Gown; Stephen M Schwartz
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

10.  Defecation of a "colon cast" as a rare presentation of acute graft-versus-host disease.

Authors:  Hamad Al Ashgar; Musthafa Peedikayil; Naeem Chaudhri; Abdulmonem Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.